当前位置:首页 - 行情中心 - 科拓生物(300858) - 财务分析

科拓生物

(300858)

  

流通市值:34.57亿  总市值:46.53亿
流通股本:1.96亿   总股本:2.63亿

科拓生物(300858)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.15亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益185777.94万元,未分配利润42976.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产202730.90万元,负债16952.96万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入84,995,927.91365,922,713.74267,389,193.46163,345,625.11
营业总成本67,836,659.83270,340,701.74187,404,480.84119,905,813.02
其他经营收益
营业利润17,021,663.75104,603,445.488,510,411.7349,872,345.67
利润总额17,023,290.38103,829,959.5288,495,556.0549,881,660.46
净利润14,951,299.7494,519,402.4376,231,997.7341,205,063.04
每股收益
其他综合收益-4.64-19.81-52.579.89
综合收益总额14,951,295.194,519,382.6276,231,945.1641,205,072.93
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计920,624,866.76977,337,850.03975,328,659.821,032,449,376.3
非流动资产:
非流动资产合计1,106,684,157.561,041,571,040.56965,530,794.63911,142,935.19
资产总计2,027,309,024.322,018,908,890.591,940,859,454.451,943,592,311.49
流动负债:
流动负债合计119,054,078.4127,600,280.4684,246,871.1124,147,854.13
非流动负债:
非流动负债合计50,475,564.0148,480,523.3230,337,11028,195,856.24
负债合计169,529,642.41176,080,803.78114,583,981.1152,343,710.37
所有者权益(或股东权益):
归属于母公司股东权益合计1,857,779,381.911,842,828,086.811,826,275,473.351,791,248,601.12
股东权益合计1,857,779,381.911,842,828,086.811,826,275,473.351,791,248,601.12
负债和股东权益合计2,027,309,024.322,018,908,890.591,940,859,454.451,943,592,311.49
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计89,978,579.51447,875,156.93294,376,423.8173,186,880.43
经营活动现金流出小计82,828,680.19324,433,516.31221,778,122.01145,303,888.15
经营活动产生的现金流量净额7,149,899.32123,441,640.6272,598,301.7927,882,992.28
投资活动产生的现金流量:
投资活动现金流入小计859,450,015.171,104,035,227.53976,191,724.42605,494,027.97
投资活动现金流出小计756,767,729.261,193,002,361.221,016,273,106.16675,793,345.02
投资活动产生的现金流量净额102,682,285.91-88,967,133.69-40,081,381.74-70,299,317.05
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计416,09440,413,537.4940,366,756.04658,865
筹资活动产生的现金流量净额-416,094-40,413,537.49-40,366,756.04-658,865
汇率变动对现金及现金等价物的影响-4.64-19.81-52.829.89
现金及现金等价物净增加额109,416,086.59-5,939,050.37-7,849,888.81-43,075,179.88
期末现金及现金等价物余额209,062,403.6999,646,317.197,735,478.6662,510,187.59
补充资料:
现金及现金等价物的净增加额--5,939,050.37--43,075,179.88
最新报告期:2026-05-13
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长城证券刘鹏,袁紫馨0.370.500.672026-05-13
华源证券周翔,张东雪,林若尧0.450.610.942026-05-06
TOP↑